Dysglycaemia: A cardiovascular risk factor

Diabetes Research and Clinical Practice

Volumn 40, Issue SUPPL., 1998, Pages

  Gerstein, Hertzel C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Cardiovascular disease; Diabetes; Hyperglycaemia; Risk factor

Indexed keywords

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; MICROVASCULATURE; RISK FACTOR;

EID: 0031850284     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8227(98)00036-9     Document Type: Conference Paper

References (33)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997) 1183-1197.
2. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977-986.
3. Y. Ohkubo, H. Kishikawa, E. Araki, et al., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res. Clin. Pract. 28 (1995) 103-117.
4. United Kingdom Prospective Diabetes Study Group, R. Turner, C. Cull, R. Holman, United Kingdom Prospective Diabetes Study 17: A 9 year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus, Ann. Intern. Med. 124 (1996) 136-145.
5. W.B. Kannel, D.L. McGee, Diabetes and cardiovascular disease. The Framingham study, J. Am. Med Assoc. 241 (1979) 2035-2038.
6. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth, Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial, Diabetes Care 16 (1993) 434.
7. J.H. Fuller, M.J. Shipley, G. Rose, R.J. Jarrett, H. Keen, Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study, Br. Med. J. Clin. Res. Ed. 287 (1983) 867-870.
8. E. Barrett-Connor, B.A. Cohn, D.L. Wingard, S.L. Edelstein, Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study, J. Am. Med. Assoc. 265 (1991) 627-631.
9. U. Goldbourt, S. Yaari, J.H. Medalie, Factors predictive of long-term coronary heart disease mortality among 10059 male Israeli civil servants and municipal employees. A 23 year mortality follow-up in the Israeli Ischemic Heart Disease Study, Cardiology 82 (1993) 100-121.
10. J.E. Manson, G.A. Coldlitz, M.J. Stampfer, et al., A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women, Arch. Intern. Med. 151 (1991) 1141-1147.
11. S.E. Moss, R. Klein, B.E.K. Klein, S.M. Meuer, The association of glycaemia and cause-specific mortality in a diabetic population, Arch. Intern. Med. 154 (1994) 2473-2479.
12. J. Kuusisto, L. Mykkanen, K. Pyorala, M. Laakso, NIDDM and its metabolic control predict coronary heart disease in elderly subjects, Diabetes 43 (1994) 960-967.
13. D.K.G. Andersson, K. Svardsudd, Long-term glycaemic control relates to mortality in type II diabetes, Diabetes Care 18 (1995) 1534-1543.
14. M. Gall, K. Borch-Johnsen, P. Hougaard, F.S. Nielsen, H. Parving, Albuminuria and poor glycaemic control predict mortality in NIDDM, Diabetes 44 (1995) 1303-1309.
15. S. Agewall, J. Wikstrand, S. Ljungman, B. Fagerberg, Risk Factor Intervention Study Group. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus, Am. J. Cardiol. 80 (1997) 164-169.
16. K. Malmberg, L. Ryden, S. Efendic, et al., Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year, J. Am. Coll. Cardiol. 26 (1995) 57-65.
17. DIGAMI Study Group, K. Malmberg, Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus, Br. Med. J. 314 (1997) 1512-1515.
18. Diabetes Control and Complications Trial (DCCT) Research Group, Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial, Am. J. Cardiol. 75 (1995) 894-903.
19. C. Scheidt-Nave, E. Barrett-Connor, D.L. Wingard, B.A. Cohn, S.L. Edelstein, Sex differences in fasting glycaemia as a risk factor for ischemic heart disease death, Am. J. Epidemiol. 133 (1991) 565-576.
20. Y.W.G. Yarnell, J.E. Pickering, P.C. Elwood, et al., Does non-diabetic hyperglycaemia predict future IHD? Evidence from the Caerphilly and Speedwell studies, J. Clin. Epidemiol. 47 (1994) 383-388.
21. MRFIT Research Group, B.J. Shaten, L.H. Kuller, J.D. Neaton, Association between baseline risk factors, cigarette smoking and CHD mortality after 10.5 years, Prev. Med. 20 (1991) 655-669.
22. J.H. Fuller, M.J. Shipley, G. Rose, R.J. Jarrett, H. Keen, Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study, Lancet 8183 (1980) 1373-1376.
23. B. Balkau, E. Eschwege, L. Papoz, et al., Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status, Br. Med. J. 307 (1993) 295-299.
24. R.P. Donahue, R.D. Abbott, D.M. Reed, K. Yano, Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program, Diabetes 36 (1987) 689-692.
25. O. Vaccaro, K.J. Ruth, J. Stamler, Relationship of post-load plasma glucose to mortality with 19-year follow-up, Diabetes Care 15 (1992) 1328-1334.
26. K. Pyörälä, E. Savolainen, S. Kaukola, J. Haapakoski, Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study Population, Acta Med. Scand. 701 (Suppl.) (1985) 38-52.
27. K. Pyorala, E. Savolainen, E. Lehtovirta, S. Punsar, P. Siltanen, Glucose tolerance and coronary heart disease: Helsinki Policemen Study, J. Chronic Dis. 32 (1979) 729-745.
28. E.J.M. Feskens, D. Kromhout, Glucose tolerance and the risk of cardiovascular diseases: the Zutphen study, J. Clin. Epidemiol. 45 (1992) 1327-1334.
29. M. Coutinho, Y. Wang, H.C. Gerstein, S. Yusuf, Continuous relationship of glucose with cardiovascular events in non-diabetic subjects: a meta regression analysis of 18 studies in 88000 individuals, Circulation 94 (1996) 1-214 Abstract.
30. P. Pais, J. Pogue, H. Gerstein, et al., Risk factors for acute myocardial infarction in Indians: a case-control study, Lancet 348 (1996) 358-363.
31. H.C. Gerstein, S. Yusuf, Dysglycaemia and risk of cardiovascular disease, Lancet 347 (1996) 949-950.
32. S,J. Kenny, R.E. Aubert, L.S. Geiss, Prevalence and incidence of non-insulin-dependent diabetes, in: M.I. Harris, C.C. Cowie, M.S. Stern, E.J. Boyko, G.E. Reiber, P.H. Bennett (Eds.), Diabetes in America. Second ed. National Institutes of Health, NIH Publication No. 95-1468, 1995, pp. 47-68.
33. L.L. Vitelli, E. Shahar, G. Heiss, et al., Glycosylated hemoglobin level and carotid intimal-medial thickening in non-diabetic individuals. The Atherosclerosis Risk in Communities Study, Diabetes Care 20 (1997) 1454-1458.